KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 4,925.00
-175.00 (-3.43%)
At close: Feb 20, 2026
KoBioLabs Market Cap
KoBioLabs has a market cap or net worth of 95.64 billion as of February 20, 2026. Its market cap has decreased by -5.79% in one year.
Market Cap
95.64B
Enterprise Value
77.44B
Revenue
71.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,925.00
Market Cap Chart
Since November 18, 2020, KoBioLabs's market cap has decreased from 493.16B to 95.64B, a decrease of -80.61%. That is a compound annual growth rate of -26.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 99.04B | -10.99% |
| Dec 30, 2025 | 111.27B | 7.15% |
| Dec 30, 2024 | 103.84B | -35.34% |
| Dec 28, 2023 | 160.60B | -16.02% |
| Dec 29, 2022 | 191.23B | -42.95% |
| Dec 30, 2021 | 335.17B | -50.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CORESTEMCHEMON | 144.84B |
| BIO-FD&C | 134.70B |
| TegoScience | 115.86B |
| IMGT Co.,Ltd. | 104.76B |
| CTCBIO | 100.30B |
| Naturalendo Tech | 94.25B |
| Cell Biotech | 94.10B |
| Progen | 93.48B |